Evidence map›Paper›PMID 35337006›Full record

ArticleViruses2022

A Novel H-2

Ida Uddbäck, Jacob E Kohlmeier, Allan R Thomsen, Jan P Christensen

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ida UddbäckDepartment of Immunology and Microbiology, University of Copenhagen, DK-2200 Copenhagen, Denmark.ORCID 0000-0001-6007-5918
Jacob E KohlmeierDepartment of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA.
Allan R ThomsenDepartment of Immunology and Microbiology, University of Copenhagen, DK-2200 Copenhagen, Denmark.ORCID 0000-0002-2392-9803
Jan P ChristensenDepartment of Immunology and Microbiology, University of Copenhagen, DK-2200 Copenhagen, Denmark.ORCID 0000-0002-4299-9479

Funding

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Cellular and molecular programming of lung resident T cell memoryR35HL150803 · NHLBI · EMORY UNIVERSITY · PI JACOB E KOHLMEIER · 2020 to 2026
$5.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS R35 HL150803NIAID NIH HHS 75N93022D00005NIDA NIH HHS 75N95020D00005ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Understanding the complexity of the T-cell epitope hierarchy in humans through mouse models can be difficult. In particular, using only one murine strain, the C57BL/6 mouse, to investigate the immune response to influenza virus infection limits our understanding. In the present study, by immunizing C57BL/6 mice with an adenoviral vector encoding the polymerase acidic (AdIiPA) protein of influenza A virus, we were able to induce a high number of PA-specific T cells. However, upon challenge, these cells were only partly protective. When instead immunizing BALB/c mice with AdIiPA, we found that the immunized mice were fully protected against challenge. We found that this protection was dependent on CD8 T cells, and we identified a novel H-2D

Indexed as

Influenza, HumanInfluenza VaccinesOrthomyxoviridae InfectionsAnimalsCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHumansMiceMice, Inbred BALB CMice, Inbred C57BLEpitopes, T-LymphocyteInfluenza Vaccinesadenoviral vaccinesadenovirusinfluenza vaccinemucosal immunitymurine modelsT cellT-cell immunity

Identifiers

PMID35337006
PMCPMC8949235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.